HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Guillaume Velasco Selected Research

variable Immunodeficiency syndrome

1/2023Novel compound heterozygous mutations in UHRF1 are associated with atypical immunodeficiency, centromeric instability and facial anomalies syndrome with distinctive genome-wide DNA hypomethylation.
1/2019CDCA7 and HELLS mutations undermine nonhomologous end joining in centromeric instability syndrome.
1/2017Telomeres in ICF syndrome cells are vulnerable to DNA damage due to elevated DNA:RNA hybrids.
9/2014Dnmt3b Prefers Germ Line Genes and Centromeric Regions: Lessons from the ICF Syndrome and Cancer and Implications for Diseases.
4/2014Germline genes hypomethylation and expression define a molecular signature in peripheral blood of ICF patients: implications for diagnosis and etiology.
7/2013Three novel ZBTB24 mutations identified in Japanese and Cape Verdean type 2 ICF syndrome patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Guillaume Velasco Research Topics

Disease

6variable Immunodeficiency syndrome
01/2023 - 07/2013
6Neoplasms (Cancer)
01/2017 - 01/2008
3Breast Neoplasms (Breast Cancer)
09/2015 - 01/2008
2Carcinogenesis
01/2017 - 11/2011
1Neurodevelopmental Disorders
04/2021
1Aneuploidy (Aneuploid)
01/2017
1Pancytopenia
02/2016
1Chromosomal Instability (Chromosome Stability)
09/2014
1Intellectual Disability (Idiocy)
04/2014
1Reinfection
04/2014
1Myotonic Dystrophy (Dystrophia Myotonica)
01/2011
1Genomic Instability
05/2010

Drug/Important Bio-Agent (IBA)

4Protein Isoforms (Isoforms)IBA
09/2015 - 01/2011
3DNA (Deoxyribonucleic Acid)IBA
01/2023 - 07/2013
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
09/2015 - 01/2008
2Biomarkers (Surrogate Marker)IBA
04/2021 - 04/2014
2ChromatinIBA
01/2019 - 05/2010
2HeterochromatinIBA
01/2017 - 09/2014
1MethyltransferasesIBA
01/2023
1Proteins (Proteins, Gene)FDA Link
01/2019
1anthraceneIBA
01/2017
1Acetates (Acetic Acid Esters)FDA Link
01/2017
1Carrier Proteins (Binding Protein)IBA
01/2017
1RNA (Ribonucleic Acid)IBA
01/2017
1Immunoglobulins (Immunoglobulin)IBA
04/2014
1CytosineIBA
05/2010
1LuciferasesIBA
02/2008
1Estrogen Receptor alphaIBA
02/2008
1beta-Globins (beta Globin)IBA
02/2008
1Estrogen ReceptorsIBA
02/2008
1Estrogens (Estrogen)FDA Link
02/2008
1Neuropilin-1IBA
01/2008

Therapy/Procedure

1Hematopoietic Stem Cell Transplantation
02/2016